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Edited by Gianni CesareniAbstract The CSF-1 receptor is a protein-tyrosine kinase that
has been shown to undergo regulated intramembrane proteolysis,
or RIPping. Here, we have compared receptor downregulation
and RIPping in response to CSF-1 and TPA. Our studies show
that CSF-1 is a relatively poor inducer of RIPping and that
CSF-1-induced receptor downregulation is largely independent
of RIPping. TPA is a strong inducer of RIPping and TPA-
induced receptor downregulation is mediated by RIPping. We
further found that RIPping is dependent on TACE or a
TACE-like protease, that CSF-1 and TPA use independent path-
ways to initiate RIPping, and that the intracellular domain is
targeted for degradation through ubiquitination.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Colony-stimulating factor 1 (CSF-1) is a critical regulator of
monocyte proliferation, their diﬀerentiation into macrophages
as well as macrophage activation [1–3]. The receptor for CSF-1
is a protein-tyrosine kinase [4]. It is well established that the
CSF-1 receptor, like other receptor protein-tyrosine kinases,
uses autophosphorylation sites to select and activate intracellu-
lar signaling proteins [5–11]. We have previously shown that
the CSF-1 receptor also undergoes regulated intramembrane
proteolysis resulting in the release of the intracellular domain
into the cell [12].
Regulated intramembrane proteolysis, or RIPping, is a
highly conserved process that is used by a wide variety of
organisms [13–15]. RIPping involves two cleavage events.
First, an integral membrane protein is cleaved within its extra-
cellular region close to the plasma membrane. This results in
ectodomain shedding and yields a truncated integral mem-
brane protein with a very short extracellular domain [13–15].
The truncated product of the ﬁrst cleavage is recognized by a
second protease, often c-secretase, that cleaves proteins within
their transmembrane region [16,17]. Intramembrane cleavage
results in the release of the intracellular domain (ICD) into*Corresponding author. Fax: +1 619 594 4634.
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doi:10.1016/j.febslet.2007.10.031the cytosol. The intracellular domain generally moves to the
nucleus where it is likely to participate in the activation of gene
transcription [16,17].
RIPping provides a mechanism for CSF-1 receptor down-
regulation, as well as a mechanism for signal transduction.
In this study we have compared RIPping induced by CSF-1
with RIPping induced by TPA.2. Materials and methods
2.1. Reagents
Recombinant human CSF-1 was obtained from R&D Systems
(Minneapolis, MN). A polyclonal antiserum was raised previously in
our laboratory against the kinase insert domain of the murine CSF-1
receptor [10]. A monoclonal antibody against ubiquitin was purchased
from Cell Signaling Technology (Danvers, MA), TAPI-0 was pur-
chased from Calbiochem (San Diego, CA) and TPA was purchased
from Sigma–Aldrich (St Louis, MO).
2.2. Cell culture
The murine macrophage cell line, P388D1, was obtained from Dr.
Ed Dennis (UCSD, San Diego, CA) and was grown in Iscove’s mod-
iﬁed Eagles media supplemented with 10% fetal bovine serum. Cells
were grown at 10% CO2. P388D1 cells were seeded at 2–3 · 105 cells
per ml in a 10 cm dish two days prior to stimulation.2.3. Immunoprecipitation
Cells were stimulated as described in the text, rinsed two times with
cold TBS, and lysed in PLC lysis buﬀer (50 mM HEPES, pH 7.5,
150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl2,
1 mM EGTA, 100 mM NaF, 10 mM Na pyrophosphate, 500 lM Na
orthovanadate, 1 mM AEBSF, 1 lM leupeptin, 1 mM benzamidine,
and 1 lM E64). Lysates were cleared by centrifugation at 10000 rpm
in a microcentrifuge at 4 C, incubated with 0.5 ll polyclonal anti-
CSF-1 receptor antiserum 1 h on ice and subsequently with 100 ll
10% Protein A-Sepharose for 1 h at 4 C on an agitator. Sepharose
beads were collected by centrifugation and washed four times with
PLC lysis buﬀer. Immunoprecipitates were boiled 3 min in 62.5 mM
Tris/Cl pH 6.8, 10% glycerol, 5% b-mercaptoethanol, 5 mM DTT,
2.3% SDS, and 0.025% Bromophenol Blue (SDS–sample buﬀer) and
resolved by SDS–PAGE on a 7% acrylamide gel.2.4. Immunoblotting
Proteins were transferred to PVDF membranes using a Biorad semi-
dry blotting apparatus at 50 mA per gel for 45 min at room tempera-
ture. Membranes were blocked for 1 h at room temperature in 10 mM
Tris/Cl pH 7.4, 150 mM NaCl, 0.2% Tween 20 (TBST) containing 5%
dried milk and incubated with 1:700 dilution of the polyclonal anti-
CSF-1 receptor serum in TBST 5% milk for 1 h at room temperature.
Blots were washed 2 · 10 min with TBST and 2 · 5 min with 10 mM
Tris/Cl pH 7.4 and 150 mM NaCl (TBS). Membranes were then incu-
bated for 30 min with HRP-Protein A (BioRad, Hercules, CA) dilutedblished by Elsevier B.V. All rights reserved.
5378 G. Glenn, P. van der Geer / FEBS Letters 581 (2007) 5377–53811:10000 in TBST and washed as before. For detection of ubiquitin, the
blot was incubated overnight with a 1:1000 dilution of the antibody in
TBST 5% dried milk. HRP-linked goat anti-mouse Ig diluted 1:10000
was used as secondary antibody. Reactive proteins were visualized by
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Fig. 2. CSF-1 and TPA induce CSF-1 receptor RIPping with diﬀerent
kinetics. P388D1 cells were stimulated with CSF-1 (100 ng/ml) or TPA
(100 nM) for varying lengths of time, the cells were lysed, and CSF-1
receptor immunoprecipitates were analyzed by anti-CSF-1 receptor
immunoblotting.3. Results
3.1. Concentration dependent processing of the CSF-1 receptor
in response to CSF-1 or TPA
To determine at what concentration CSF-1 and TPA induce
maximal levels of RIPping, P388D1 macrophage cells were
incubated with various concentrations of these activators for
20 min. The cells were then lysed; receptors were isolated by
immunoprecipitation and visualized by immunoblotting with
an antiserum directed against the CSF-1 receptor kinase insert
domain (Fig. 1). Protein bands of 150, 130 and 55 kDa were
detected on these blots. The 150 kDa protein represents the
mature receptor present on the cell surface; the 130 kDa pro-
tein corresponds to a precursor protein present in the endo-
plasmic reticulum; the 55 kDa protein is produced by
RIPping and is composed largely of the intracellular domain
(ICD) of the CSF-1 receptor (Fig. 1). It is only the 150 kDa
mature receptor that is subject to RIPping, the 130 kDa pre-
cursor is unaﬀected (Fig. 1). Our results show a low level of
constitutive CSF-1 receptor RIPping. Stimulation with CSF-
1 causes a small but reproducible increase in the level of the
ICD. Maximal levels were observed with 100 ng/ml CSF-1
(Fig. 1A). The results also show that the decrease in the levels
of mature receptors correlates poorly with the increase in levels
of the ICD. This is a consequence of the fact that CSF-1 causes
most receptors to be internalized and degraded in the lyso-
somes, while a smaller fraction is subject to RIPping.
Stimulation with TPA also results in a concentration depen-
dent induction of RIPping. We detected an increase in RIP-
ping with as little as 10 nM TPA, while maximal RIPping
was observed with 100 nM TPA (Fig. 1B). In contrast to what
was found with CSF-1, the decrease in levels of mature recep-
tors correlates well with the increase in levels of the ICD.
3.2. CSF-1 and TPA-induced RIPping follow diﬀerent time
courses
To ﬁnd out whether CSF-1 and TPA use the same pathway
to induce CSF-1 receptor RIPping we carried out a time course
experiment. P388D1 macrophages were stimulated with either
CSF-1 or TPA for various amounts of time and analyzed for
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Fig. 1. Dose-dependent RIPping of CSF-1 receptors in response to CSF-1 or
(A) or TPA (B) for 20 min, the cells were lysed and CSF-1 receptor immun
Protein bands representing the mature receptor (CSF-1R), the CSF-1R precICD. The experiment shows that receptors start to disappear
within minutes after addition of CSF-1. Maximal receptor
downregulation is seen at 30 min (Fig. 2A). The ICD ﬁrst ap-
pears at 5 min after addition of CSF-1, maximal levels are seen
at 20–30 min after which the ICD slowly disappears (Fig. 2A).
Downregulation of receptors may be slightly slower in re-
sponse to TPA while the ICD levels peak a little earlier
(Fig. 2B). These observations show that both CSF-1 and
TPA induce RIPping, but that the kinetics of this process de-
pends on the stimulus.
3.3. CSF-1 is largely independent of PKC for the induction of
RIPping
To investigate whether CSF-1 depends on the presence of
PKC for the induction of RIPping, P388D1 cells were
pretreated with TPA or DMSO for 24 h to downregulate
expression of PKC, prior to stimulation. CSF-1-induced
disappearance of mature receptors and the appearance of the
ICD were largely unaﬀected by the absence of PKC
(Fig. 3A). In contrast, the TPA-induced disappearance of0 0.3 1 3 10 30 100 300 nM TPA
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30
95
72
55
CSF-1R
ICD
precursor
TPA. P388D1 cells were stimulated with increasing amounts of CSF-1
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Fig. 3. CSF-1 and TPA-induced RIPping diﬀer in their dependence on the presence of PKC. P388D1 cells were treated for 24 h with 100 nM TPA or
DMSO as a control. Cells were then stimulated with CSF-1 or TPA, the cells were lysed, and CSF-1 receptor immunoprecipitates were analyzed by
anti-CSF-1 receptor immunoblotting.
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blocked completely following downregulation of PKC
(Fig. 3B). These observations suggest that CSF-1 and TPA
are using diﬀerent pathways to stimulate receptor downregula-
tion as well as RIPping.
3.4. TACE inhibitors diﬀerentially aﬀect CSF-1 and TPA-
induced downregulation of the CSF-1 receptor
To investigate the involvement of TACE in CSF-1 and TPA-
induced RIPping and receptor downregulation, P388D1 mac-
rophages were pretreated with the TACE inhibitor TAPI-0
for 1 h before stimulation. Our results show that the inhibitor
has very little eﬀect on receptor disappearance in response to
CSF-1, while it almost completely blocked receptor disappear-
ance in response to TPA. These observations show that much
of CSF-1-induced receptor downregulation is independent of
TACE. In contrast, TPA-induced receptor downregulation ap-
pears to be completely dependent on TACE. This supports the
notion that TPA-induced receptor downregulation is mediated
by RIPping, while CSF-1-induced receptor downregulation is
not.
3.5. Ubiquitination of the CSF-1 receptor intracellular domain
During the course of our experiments we observed that
hydrogen peroxide cooperates with other stimuli in the induc-
tion of CSF-1 receptor RIPping (results not shown). These
experiments further showed the generation of a series of
ICD-related proteins of increasing size. To investigate the pos-
sibility that the CSF-1 receptor ICD becomes ubiquitinated,A
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Fig. 4. The TACE inhibitor, TAPI-0, diﬀerentially inhibits CSF-1 and TPA-
with 100 lM TAPI-0, the cells were lysed, and CSF-1 receptor immunoprecCSF-1 receptor immunoprecipitates from hydrogen peroxide
treated cells were analyzed by anti-ubiquitin immunoblotting.
The results show indeed a series of proteins of increasing size
that can be detected with an anti-CSF-1 receptor antibody
(Fig. 5, left panel). Most of these proteins can also be detected
by anti-ubiquitin immunoblotting (Fig. 5, right panel). These
results show that the CSF-1 receptor ICD is modiﬁed by ubiq-
uitination, likely marking the ICD for degradation in the pro-
teasome.4. Discussion
Macrophages play an important role in the defense against
foreign intruders and in tissue development. In addition, they
have been implicated in the etiology of various maladies
including diabetes and heart disease [18,19]. The CSF-1 recep-
tor regulates the renewal and survival of macrophages, recruit-
ment of macrophages to speciﬁc sites within the body, and
macrophage activation [1–3,20]. We have shown that the
CSF-1 receptor can undergo RIPping [12]. CSF-1 receptor
RIPping and transient accumulation of the ICD are seen fol-
lowing activation of Toll-like receptors (Glenn and van der
Geer, unpublished observations), suggesting that RIPping
may play a role during macrophage activation and initiation
of the innate immune response. We believe that following its
release from the plasma membrane the ICD travels to the nu-
cleus, where it may contribute to regulation of pro-inﬂamma-
tory gene transcription.0 20 60 200 60
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minutes TPA
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B
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Fig. 5. P388D1 cells were treated with 3 mM hydrogen peroxide for
varying lengths of time, the cells were lysed, and CSF-1 receptor
immunoprecipitates were analyzed by anti-CSF-1 receptor and anti-
ubiquitin immunoblotting.
5380 G. Glenn, P. van der Geer / FEBS Letters 581 (2007) 5377–5381In this study, we have compared RIPping in response to
either CSF-1 or TPA. The results show that CSF-1 is a rela-
tively poor inducer of RIPping (Fig. 1). This suggests that
when cells are stimulated with CSF-1 alone, most receptors
disappear through internalization and degradation in the lyso-
somes. Consequently, RIPping makes only a small contribu-
tion CSF-1-induced signaling or receptor downregulation
(Fig. 6). On the other hand, RIPping is more robustly induced
by TPA, suggesting that CSF-1 receptor RIPping is likely to
contribute to signaling by receptors that strongly activate
PKC, presumably through activation of phospholipase C
[21]. In addition, the possibility exists that RIPping is stronglyinternalization
outside
inside
lysosomal
degradation
CSF-1
CSF-1
receptor
Fig. 6. CSF-1 and TPA induced receptor downregulation and RIPping. Stim
are removed from the cell surface by internalization and degradation in the ly
undergo RIPping. Activation of PKC by TPA results in robust activation of
intramembrane proteolysis. All TPA induced CSF-1 receptor downregulatioinduced when cells are stimulated with CSF-1 and one or more
other cytokines. This is relevant because macrophages encoun-
ter various diﬀerent cytokines during the onset of inﬂamma-
tion [22,23].
It has been shown previously that TACE is involved in
CSF-1 receptor downregulation [24]. This prompted us to
investigate whether TACE is essential for either CSF-1 or
TPA-induced RIPping. The results show CSF-1-induced
receptor downregulation is largely unaﬀected by the presence
of TACE inhibitors. This suggests that CSF-1-dependent
receptor downregulation is not mediated by RIPping
(Fig. 6). TPA dependent CSF-1 receptor downregulation,
however, is completely blocked in the presence of 100 lM
TAPI-0. This suggests that TPA-induced receptor downregula-
tion is mediated entirely by RIPping (Fig. 6). Interestingly, the
appearance of the ICD is not completely blocked by TACE
inhibitors (Fig. 4B), suggesting that TPA may activate a
TACE-related protease such as Kuz or one of the meltrins,
all of which are known to act as ectodomain sheddases [25].
Time course experiments of CSF-1 and TPA induced CSF-1
receptor downregulation agree largely with previously pub-
lished observations [26,27]. Small diﬀerences may be due to dif-
ferences in the cell lines studied or in the methods used to
assess the presence of the CSF-1 receptor. In response to
CSF-1, the levels of the ICD keep rising for up to 30 min. In
contrast, when cells are stimulated with TPA maximal levels
of the intracellular domain can be observed at 15 min after
the onset of stimulation. It is unclear what causes this diﬀer-
ence. However, it suggests that CSF-1 and TPA may activatePKC
TPA
pm
ectodomain
shedding
γ-secretase
intramembrane
proteolysis
ubiquitination
and proteasomal
degradation
TACE
ulation with CSF-1 causes receptor activation. Most activated receptors
sosomes (blue arrows). CSF-1 causes a small fraction of its receptors to
TACE or a TACE-like protease followed by ectodomain shedding and
n is mediated by RIPping (pink arrows).
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This model is further supported by results showing that TPA-
induced RIPping depends on the presence of PKC, while CSF-
1 receptor induced RIPping does not (Fig. 2). Together these
observations support the conclusion that CSF-1 and TPA acti-
vate independent pathways leading to receptor RIPping
(Fig. 6).
We have shown that CSF-1 receptor RIPping is initiated by
cleavage within the receptor’s extracellular domain that is
mediated by TACE or a related protease. There are at least
two independent pathways that lead to CSF-1 receptor RIP-
ping (Fig. 6). This suggests that RIPping is subject to regula-
tion in response to various extracellular signals and that the
release of the CSF-1 receptor intracellular domain into the
interior of the cell plays a role in signaling by a variety of cyto-
kines that regulate of macrophage activity. Following its re-
lease into the cytoplasm, the ICD is likely to move to the
nucleus, becomes ubiquitinated and is ﬁnally directed to the
proteasome for degradation (Figs. 5 and 6).
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